Skip to main content

Table 2 Associations between peripartum congestive heart failure and comorbidities

From: Epidemiological profile and obstetric outcomes of patients with peripartum congestive heart failure in Taiwan: a retrospective nationwide study

Characteristics

Crude ORa [95% CI]

Adjusted ORb [95% CI]c

1. Maternal comorbidities

 Structural heart disease

190.58 (159.81–227.27)

67.21 (54.28–83.22)

 Pulmonary disease

114.24 (94.05–138.76)

13.12 (10.28–16.75)

 Liver disease

32.99 (19.36–56.23)

3.61 (1.85–7.05)

 Renal disease

119.85 (75.33–190.68)

4.53 (2.28–8.99)

 Thyroid disease

35.16 (21.64–57.13)

9.53 (5.27–17.23)

 Anemia

7.19 (5.68–9.10)

2.99 (2.28–3.91)

 Cancer

3.89 (2.19–6.89)

1.80 (0.97–3.35)

 Autoimmune disease

47.65 (28.43–79.86)

2.33 (1.08–5.01)

 Chronic hypertension

146.58 (102.96–208.68)

11.27 (6.94–18.28)

 Diabetes mellitus

20.03 (11.01–36.46)

1.33 (0.54–3.26)

2. Obstetric conditions

 Multifetal pregnancies

5.63 (4.05–7.84)

2.13 (1.47–3.08)

 Placenta anomaly

1.79 (0.96–3.35)

1.21 (0.51–2.88)

 Gestational HTN

17.40 (13.92–21.75)

5.16 (3.89–6.85)

 Gestational diabetes mellitus

6.37 (4.12–9.87)

1.02 (0.55–1.90)

 Peripartum hemorrhage

1.98 (1.31–2.98)

0.98 (0.54–1.76)

  1. Associations between peripartum congestive heart failure and maternal comorbidities and obstetric conditions
  2. a OR: odds ratio
  3. bAdjusted for all confounding factors in Table 1
  4. c CI: confidence interval